REGISTERED NUMBER: 07048873 (England and Wales)

DHARIWAL MEDICAL LIMITED

Unaudited Financial Statements For The Year Ended 31 March 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

Report of the Accountants

7

DIRECTOR:

Dr N K Dhariwal FRCA FFFARCSI

SECRETARY:

A Dhariwal

REGISTERED OFFICE:

4 Graham Park Road

Gosforth

Newcastle

Tyne and Wear

NE3 4BH

REGISTERED NUMBER:

07048873 (England and Wales)

ACCOUNTANTS:

Ron Joyce Ltd

Chartered Certified Accountant

18 Norham Road

Whitley Bay

Tyne and Wear

NE26 2SD

FIXED ASSETS

Tangible assets

4

2,408

1,411

CURRENT ASSETS

Debtors

5

10,372

3,683

Investments

6

963,454

1,067,667

Cash at bank

131,932

11,429

1,105,758

1,082,779

CREDITORS

Amounts falling due within one year

7

3,979

939

NET CURRENT ASSETS

1,101,779

1,081,840

TOTAL ASSETS LESS CURRENT LIABILITIES

1,104,187

1,083,251

PROVISIONS FOR LIABILITIES

9

458

268

NET ASSETS

1,103,729

1,082,983

CAPITAL AND RESERVES

Called up share capital

9

9

Revaluation reserve

10

179,582

194,045

Retained earnings

924,138

888,929

SHAREHOLDERS' FUNDS

1,103,729

1,082,983

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 September 2025 and were signed by:

Dr N K Dhariwal FRCA FFFARCSI - Director

1.	STATUTORY INFORMATION

Dhariwal Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements

There were no judgements made that were significant enough to warrant disclosure.

Turnover

Turnover represents income for the sale of medical services provided and excludes VAT as the supply is exempt and the company is not VAT registered.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Significant estimates

There were no estimates made that were significant enough to warrant disclosure.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1 April 2024

5,356

Additions

1,799

At 31 March 2025

7,155

DEPRECIATION

At 1 April 2024

3,945

Charge for year

802

At 31 March 2025

4,747

NET BOOK VALUE

At 31 March 2025

2,408

At 31 March 2024

1,411

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

7,183

3,683

Other debtors

3,189

-

10,372

3,683

6.	CURRENT ASSET INVESTMENTS

2025

2024

£

£

Listed investments

963,454

1,067,667

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

2,159

(8,221

)

Other creditors

1,820

9,160

3,979

939

Included in other creditors are amounts owed to or by the Director, this year he owed £1,189 (was owed £3,542 - 2024).

8.	FINANCIAL INSTRUMENTS

Debtors are shown at their impaired value (i.e. less doubtful debts).

9.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

458

268

Deferred

tax

£

Balance at 1 April 2024

268

Provided during year

190

Balance at 31 March 2025

458

10.

RESERVES

Revaluation

reserve

£

At 1 April 2024

194,045

Revaluation reserve movement

(14,463

)

At 31 March 2025

179,582

11.	RELATED PARTY DISCLOSURES

No transactions with related parties were undertaken that required disclosure under FRS 102 section 1A small entities.

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 March 2025 set out on pages three to ten and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.

Ron Joyce Ltd

Chartered Certified Accountant

18 Norham Road

Whitley Bay

Tyne and Wear

NE26 2SD

16 September 2025